AN2 Therapeutics, Inc.(ANTX)内部人交易:高管与董事近期交易
过去 18 个月,共有 14 位内部人为 AN2 Therapeutics, Inc.(ANTX)报告了 51 笔 Form 4 交易(最近一笔 2026-11-06)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-06 | Eizen Joshua M | Chief Operating Officer and Chief Legal Officer | 卖出 | 2,826 | $11,926 |
| 2026-10-13 | Aziz Kabeer | 董事 | 买入 | 2,465 | $0 |
| 2026-10-13 | Martin Patricia A. | 董事 | 买入 | 389 | $0 |
| 2026-10-13 | Marks Gilbert Lynn | 董事 | 买入 | 2,283 | $0 |
| 2026-09-16 | Trenor Cameron C. III | Chief Medical Officer | 买入 | 116,667 | $0 |
| 2026-09-11 | Readnour Robin Shane | 董事 | 卖出 | 523 | $3,148 |
| 2026-09-11 | Readnour Robin Shane | 董事 | 卖出 | 585 | $3,522 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 2,877 | $17,463 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 3,223 | $19,564 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 4,725 | $28,444 |
| 2026-09-08 | Readnour Robin Shane | 董事 | 卖出 | 5,294 | $31,870 |
| 2026-09-04 | Williams Sarah Joanne | Principal Accounting Officer | 卖出 | 272 | $1,504 |
| 2026-09-02 | FitzPatrick Margaret M | 董事 | 买入 | 2,098 | $11,602 |
| 2026-08-19 | Readnour Robin Shane | 董事 | 卖出 | 16,696 | $100,343 |
| 2026-08-19 | Readnour Robin Shane | 董事 | 卖出 | 18,706 | $112,423 |
| 2026-08-14 | Zakrzewski Joseph S | 董事 | 卖出 | 405,880 | $0 |
| 2026-07-10 | Eizen Joshua M | Chief Operating Officer and Chief Legal Officer | 卖出 | 5,945 | $24,791 |
| 2026-07-10 | Martin Patricia A. | 董事 | 买入 | 766 | $0 |
| 2026-07-10 | Marks Gilbert Lynn | 董事 | 买入 | 2,789 | $0 |
| 2026-07-10 | Aziz Kabeer | 董事 | 买入 | 2,852 | $0 |
| 2026-06-02 | Williams Sarah Joanne | Principal Accounting Officer | 卖出 | 265 | $1,174 |
| 2026-04-10 | Aziz Kabeer | 董事 | 买入 | 3,775 | $0 |
| 2026-04-10 | Martin Patricia A. | 董事 | 买入 | 1,192 | $0 |
| 2026-04-10 | Marks Gilbert Lynn | 董事 | 买入 | 3,775 | $0 |
| 2026-03-05 | Williams Sarah Joanne | Principal Accounting Officer | 卖出 | 327 | $347 |
来源:SEC Form 4 申报文件 · 截至 2026-11-06